Humacyte's Symvess approval signals growth in regenerative medicine. See why HUMA stock is not yet a buy as we monitor its ...

Much more than computing dominance is at stake; the struggle for AI primacy between the United States, China, middle powers, ...

Bilfinger (BFLBF) is well-positioned to benefit from strong secular trends. Read more to see why I rate the stock a buy.

Meeting electricity demand for big tech data centers could give Trump reason to get behind major wires projects.

The increasing pace of disruption and change means leaders need to cultivate behaviors that support their sustained success.

From fresh graduates to seasoned leaders, the entertainment platform empowers tech talent with opportunities to innovate, ...

The Aman season has failed to stabilise the rice market due to lower imports and the failure to meet procurement targets from local sources, and now the government is focusing on rice imports to ...

THE January transfer window is now well underway – and some huge moves appear to be in the pipeline. West Ham are reportedly ...

Best in the Eastern Conference. Best in the Western Conference. The best shooting team in the NBA vs. the best defensive team ...

Protein powders may contain high levels of lead and cadmium, with chocolate-flavored and plant-based products testing at the ...

The FDA’s action, serving only as non-enforceable guidance, has been criticised by the NGO Center for Science in the Public ...

The OpenAI CEO recently published a blog post reflecting on AI progress, as well as his brief ouster from the company.